Localized Optical Coherence Tomography Precursors of Macular Atrophy and Fibrotic Scar in the Comparison of Age-Related Macular Degeneration Treatments Trials
- 19 November 2020
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 223, 338-347
Abstract
No abstract availableKeywords
Funding Information
- National Eye Institute
This publication has 34 references indexed in Scilit:
- Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments TrialsOphthalmology, 2019
- Linking OCT, Angiographic, and Photographic Lesion Components in Neovascular Age-Related Macular DegenerationOphthalmology Retina, 2018
- Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular DegenerationOphthalmology, 2016
- A paradigm shift in imaging biomarkers in neovascular age-related macular degenerationProgress in Retinal and Eye Research, 2016
- Sustained Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments TrialsJAMA Ophthalmology, 2014
- Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments TrialsOphthalmology, 2014
- Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments TrialsOphthalmology, 2014
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZONOphthalmology, 2013
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular DegenerationOphthalmology, 2012
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2011